Essential thrombocythemia terminating in pure erythroleukemia

American Journal of Hematology
Andreas KreftCharles James Kirkpatrick

Abstract

Transformation into acute leukemia is a rare event in essential thrombocythemia (ET). The blasts are usually of myeloid, rarely of megakaryoblastic differentiation. We present the case of a patient with pure erythroleukemia after a nearly 10-year course of ET, which was treated with hydroxyurea. The patient, a 58-year-old male, presented with an elevated thrombocyte count (926,000/microL) and normal values of hemoglobin and leukocytes. After 10 years of therapy with hydroxyurea, the patient developed acute leukemia of solely erythroid differentiation. Chemotherapy with cytarabine and daunorubicin resulted in incomplete remission. The patient died 2 months after diagnosis of acute erythroleukemia. Transformation of ET into erythroleukemia may demonstrate the pluripotent potential of the neoplastic hemopoietic stem cell, with the ability to cause acute leukemia not only of myeloid or megakaryoblastic but also of erythroid lineage.

References

Jun 1, 1991·The Journal of Clinical Investigation·H AhujaM Cline
Apr 27, 1995·The New England Journal of Medicine·S CortelazzoT Barbui
Jul 3, 1999·Annals of Hematology·R JantunenT Ruutu
Jan 20, 2000·Baillière's Clinical Haematology·A GeorgiiA Kreft
Mar 28, 2002·Leukemia Research·Sophie ParkFrançois Dreyfus
Sep 13, 2002·European Journal of Haematology·Javier Bolaños-MeadeEverardo Cobos
Oct 9, 2002·European Journal of Haematology·Franca RadaelliAnna-Teresa Maiolo
Nov 25, 2003·Hematology·Jerry L SpivakMonia Marchetti

❮ Previous
Next ❯

Citations

Jul 12, 2008·Cancer Genetics and Cytogenetics·Concepción VillalónMaria T Ferro
Apr 29, 2016·American Journal of Clinical Pathology·Hongmei LiHoratiu Olteanu
Jul 11, 2006·American Journal of Hematology·Gee Chuan Wong, Lai Heng Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.